APVO: Aptevo Therapeutics, Inc. Sotuvga nisbatan narx
Aptevo Therapeutics (APVO) ADAPTIR tizimi orqali bispesifik antitanalarni joriy etish yo'li bilan immuno-onkologiya segmentidagi ishtirokini kengaytirmoqda. Narxning savdoga nisbati biznesning baholanish tendentsiyasini aks ettiradi, bunda so'nggi parametr 2.90 darajasida turibdi. Kompaniyaning operatsiyalari daromadli emasligi sababli tashqi investitsiyalar va grantlarga tayanadi. Kritik darajada past likvidlik klinik sinovlarning murakkabligi bilan birgalikda sezilarli operatsion tahdidlarni yuzaga keltirmoqda.
Aptevo Therapeutics (APVO) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Jamlagan qarzning kapitalga nisbati Aptevo Therapeutics|APVO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati aptevotherapeutics.com|APVO - Kompaniyaning umumiy qarzi|Qarzning balans kapitallashuviga nisbati Aptevo|APVO - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Aptevo Therapeutics|Oraliq qoplash koeffitsiyenti aptevotherapeutics.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
APVO - Sof daromad|Kelajakdagi sof foyda Aptevo Therapeutics|APVO - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori aptevotherapeutics.com|APVO - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Aptevo|APVO - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Aptevo Therapeutics|APVO - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi aptevotherapeutics.com|APVO - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Aptevo Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:Aptevo Therapeutics, Inc. APVO
Biotehnologiya sohasidagi kapital risklari va daromadlarini muvozanatga keltirish uchun Aptevo Therapeutics (APVO) bozor qiymatini haqiqiy sotuvlarga nisbatan baholashni juda muhim deb hisoblaydi. P/S trayektoriyasini tahlil qilish orqali investor bozor kapitalizatsiyasini joriy daromadlar bilan solishtirib, biznesning fundamental barqarorligini tasdiqlaydi va bozor saraton immunoterapiya segmentidagi ADAPTIR platformasining salohiyatini qanchalik hadda ortiq baholayotganini aniqlaydi.
Aptevo Therapeutics raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|PTGX - P/S multiplikatori|Immunovant, Inc. (IMVT) - Narxning daromadga nisbati|Narxning sotuvga nisbati KNSA (kiniksa.com)|Kapitalizatsiyaning daromadga nisbati GRFS|ADPT (Adaptive Biotech) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori CLDX|AUPH - Sotuvga nisbatan narx|BioCryst - Kapitalizatsiyaning daromadga nisbati|veratx.com - Narxning daromadga nisbati|DNTH - Narxning daromadga nisbati|Sotuvga nisbatan narx Pharvaris NV|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|Tourmaline - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PGEN|PHAR (pharming.com) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori NKTR|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Immunome Bio (IMNM) - Sotuvga nisbatan narx|GOSS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KALV (kalvista.com)|SEPN: P/S multiplikatori|Pieris Pharma (PVLA) - P/S multiplikatori|Narxning daromadga nisbati Savara Corp|Rigel Corp - Narxning sotuvga nisbati|P/S multiplikatori ANAB|ATXS - Sotuvga nisbatan narx|enGene - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori RAPT Therapeutics Inc. RAPT|JBIO: Kapitalizatsiyaning daromadga nisbati|Aclaris Therapeutics, Inc - Kapitalizatsiyaning sotish hajmiga nisbati|KYTX: P/S multiplikatori|TLSA - Narx/daromad koeffitsiyenti|CABA (Cabaletta Bio) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Ventyx Biosciences Inc. (VTYX)|Narxning daromadga nisbati Theratechnologies Inc (THTX)|Narx/daromad koeffitsiyenti Avalo Therapeutics Inc|P/S multiplikatori ELDN (Eledon Pharmaceuticals)|P/S multiplikatori agenusbio.com AGEN|CLYM - Narxning daromadga nisbati|Narxning sotuvga nisbati ZURA|ATYR (aTyr) - Kapitalizatsiyaning daromadga nisbati|ADAG (Adagene Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati ImageneBio|Sotuvga nisbatan narx Shattuck Therapeutics STTK|Narxning daromadga nisbati Equillium, Inc. (EQ)|CNTB: Narxning sotuvga nisbati|P/S multiplikatori IMUX (Immunic)|Bozor kapitallashuvining daromadga nisbati ATRA|InflaRx GmbH - P/S multiplikatori|XFOR - P/S multiplikatori|adicetbio.com (ACET) - Narxning daromadga nisbati|Celularity - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati INmune Bio Corp|Kapitalizatsiyaning daromadga nisbati Barinthus Biotherapeutics Corp (BRNS)|P/S multiplikatori KZR|P/S multiplikatori sabbiotherapeutics.com (SABS)|Akari Therapeutics Plc - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ENLV|Q32 Bio Corp - P/S multiplikatori|Narx/daromad koeffitsiyenti GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati ibioinc.com|Narxning daromadga nisbati Carisma Therapeutics Inc|Kapitalizatsiyaning daromadga nisbati XTL Biopharmaceuticals Ltd (XTLB)|Kapitalizatsiyaning daromadga nisbati BOLT (Bolt Biotherapeutics)|P/S multiplikatori hcwbiologics.com (HCWB)|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX: Kapitalizatsiya va daromad nisbati|GRI Bio - P/S multiplikatori|Sotuvga nisbatan narx XORTX Therapeutics Inc|HIND: P/S multiplikatori|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Narxning daromadga nisbati Indaptus Therapeutics|scinai.com - Narxning sotuvga nisbati|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|Kapitalizatsiyaning sotish hajmiga nisbati AFMD|P/S multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - Sotuvga nisbatan narx|IGMS: Kapitalizatsiyaning daromadga nisbati|ITOS: Narxning daromadga nisbati|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|Sotuvga nisbatan narx TC BioPharm (Holdings) Plc (TCBP)|Kapitalizatsiyaning daromadga nisbati THRD
